Clinical Immunology and Allergy Section (CIAS)
The BSI has a special section within the Society, which particularly focuses on the priorities and needs of its clinical members.
Membership is open and inclusive of those involved in Clinical Immunology and Allergy, including nurses in immunology and allergy, biomedical scientists, clinical scientists, researchers, trainees, and clinical immunologists and allergists. It is NOT intended to be a section solely for consultant clinical immunologists, or to replace activities of other professional organisations such as ACSI/IBMS etc., but to provide a unique single, authoritative, well-funded forum for all practitioners of Immunology, to interact for the benefit of the speciality, with access to the facilities, kudos and support of a major international scientific society.
Members who have an interest in clinical matters are invited to join the CIAS by updating their membership profile
Organisation of the CIAS
The formation of the CIAS was approved by the BSI's Board of Trustees in 2006. We now have a Clinical Secretary
on board, who is the Chair of the CIAS Executive Committee
, formed of nominated representatives from key organisations.
Aims of the CIAS:
- To foster excellence in the practice of immunological medicine
- The creation of a section of the BSI able to represent the wider Clinical Immunology and Allergy community
- To reduce fragmentation, and allow the community to speak with one voice at trust, college and Department of Health level
- To enhance communication between the scientific and Clinical Immunology communities
Please click here
to view the full constitution of the CIAS. Minutes from the CIAS Executive Committee are available here
(please note that you must be logged in to access these documents).
Improving Quality in Allergy Services (IQAS) Registration Scheme
The IQAS registration scheme is a project from the Royal College of Physicians and Royal College of Pathologists Joint Committee on Immunology and Allergy (JCIA), which aims to improve the quality of NHS specialist adult allergy services.
The RCP – with additional financial support from the British Society for Allergy and Clinical Immunology, the British Society for Immunology and the Royal College of Pathologists – have agreed to fund the implementation and management of the scheme under the auspices of the RCP Accreditation Unit
In order to join the IQAS registration scheme, allergy services will have to meet a certain level of quality standards. The standards are based on a combination of those set out in the allergy chapter of the RCP’s blueprint for medical services in hospitals, Consultant physicians working with patients, and expert opinion from the allergy community. They are currently a minimum set of standards.
The JCIA and RCP Accreditation Unit agree that at this stage IQAS should be referred to as a 'registration' scheme rather than an 'accreditation' scheme. This is because registration currently involves self-assessment rather than routine inspection. Rigorous clinical service accreditation standards and evidence requirements are currently being developed by the IQAS steering group, with the intention of launching the IQAS accreditation scheme in the second half of 2014.